Without patent protection, no pharmaceutical company can recoup the $100M+ cost of running the clinical trials required for FDA approval
This evaluation considers formulation quality, concentration, price per unit of active ingredient, user experiences, and scientific backing
By 10 years postoperative, only 10 percent of patients available for data collection (35% of study population) had serum screening of vitamin B 12
The short answer is that general subcutaneous injection education usually points to the abdomen, outer thigh, and upper arm, but that does not make injectable GHK-Cu an approved medication or a safe self-treatment
Individuals with certain health conditions, such as Lebers disease (a rare inherited eye disease), should avoid B12 supplements as it can worsen the condition